Truvian Sciences: Raises More Than $105M in Series C Financing USA

  • Truvian Sciences, a San Diego, CA-based closed more than $105m in a Series C financing
  • The round, which brought total funding to more than $150m to date, led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures
  • Truvian is a healthcare company at the intersection of diagnostics and consumer technology
  • Its automated benchtop system developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood
  • The company also announced a roster of executive and board appointments
  • Former Divisional VP of Automation and Informatics at Abbott, Jay Srinivasan, has joined the company as Chief Product Officer
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Klarna Stock Tumbles After Disappointing Q4 Results

Klarna reports unexpected losses, impacting stock performance and investor sentiment.Highlights: Klarna's stock falls sharply after reporting unexpected Q4...

FBI Warns of Surge in ATM Jackpotting Attacks

Recent spike in ATM jackpotting poses risks to financial institutions and customers.Highlights: FBI reports increased ATM jackpotting incidents...

Nvidia Considers $30 Million Investment in OpenAI

Potential investment highlights Nvidia's strategic focus on AI innovation.Highlights: Nvidia is considering a $30 million investment in OpenAI.This...

Forbes Fintech 50 Sees 20 Newcomers Strengthening Financial Inclusion

New entrants highlight AI and innovative business models in fintech.Highlights: Forbes Fintech 50 adds 20 new companies to...